TITAN PHARMACEUTICALS INC — Director's Dealing 2004

Mar 12, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTP)
CIK: 0000910267
Period of Report: 2003-10-31

Reporting Person: BUCALO LOUIS R MD (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2003-10-31	Stock Option (Right to Buy)	$3.69	A	5000	Acquired	2013-10-31	Common Stock (5000)	Direct

Footnotes

F1: This option vests in 12 equal monthly installments commencing on the date of grant.